Core Cap Advisors, LLC Tango Therapeutics, Inc. Transaction History
Core Cap Advisors, LLC
- $2.18 Billion
- Q1 2025
A detailed history of Core Cap Advisors, LLC transactions in Tango Therapeutics, Inc. stock. As of the latest transaction made, Core Cap Advisors, LLC holds 321 shares of TNGX stock, worth $712. This represents 0.0% of its overall portfolio holdings.
Number of Shares
321
Previous 748
57.09%
Holding current value
$712
Previous $2,000
100.0%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding TNGX
# of Institutions
123Shares Held
98MCall Options Held
1.1KPut Options Held
0-
Trv Gp Iv, LLC Boston, MA16.9MShares$37.4 Million88.92% of portfolio
-
Tcg Crossover Management, LLC Palo Alto, CA10.7MShares$23.8 Million3.54% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA10.6MShares$23.6 Million1.14% of portfolio
-
Nextech Invest Ag5.53MShares$12.3 Million3.19% of portfolio
-
Nextech Invest, Ltd. Zurich, V85.53MShares$12.3 Million1.76% of portfolio
About Tango Therapeutics, Inc.
- Ticker TNGX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 88,067,296
- Market Cap $196M
- Description
- Tango Therapeutics, Inc., a biotechnology company, discovers and develops drugs for the treatment of cancer. Its lead program is TNG908, a synthetic lethal small molecule inhibitor of protein arginine methyltransferase 5 that is being developed as a treatment for cancers with methylthioadenosine phosphorylase deletions. The company also develops...